中文 |

Newsroom

CT/Bioluminescence Dual-Modal Imaging to Track Mesenchymal Stem Cells in Pulmonary Fibrosis

Oct 14, 2019

Human mesenchymal stem cells (hMSCs), due to their immune regulation and collateral secretion effects, are currently being explored for potential therapy of idiopathic pulmonary fibrosis (IPF). Understanding the migration, homing, functions, as well as survival of transplanted hMSCs is critical to the successful IPF treatment. To obtain such information, development of reliable, noninvasive and real-time imaging technologies are highly desired.

Recently, a research team led by Prof. ZHANG Zhijun from Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) of the Chinese Academy of Sciences developed a dual-labeling strategy by integrating gold nanoparticle (AuNP)-based computed tomography (CT) nanotracer and red-emitting firefly luciferase (RfLuc)-based bioluminescence (BL) tag for CT/BL multimodal imaging tracking of the transplanted hMSCs in a murine model of IPF.

The novel Au@TAT nanotracer coated by polyethylene glycol (PEG) and trans-activator of transcription (TAT) exhibited favorable biocompatibility, remarkable labeling efficiency, and enhanced CT contrast, without noticeable adverse effects on the viability, proliferation and differentiation of the hMSCs. In addition, the optical imaging based on RfLuc could simultaneously increase the detection sensitivity and identify the living cells in vivo.

By corecording the CT and BLI signals from the transplanted hMSCs of the same mouse, the survival, location and distribution of the transplanted hMSCs were investigated simultaneously, thereby facilitating the profound understanding of the mechanism of the transplanted stem cells in PF treatment.

This study represents a general, facile, and versatile strategy for multimodal imaging tracking of stem cells in vitro and in vivo, which may further advance the stem cell-based therapeutics and regenerative medicine.

 

Schematic illustration of the dual-labeling CT/BLI strategy that combines the exogenous Au@TAT nanotracers and the endogenous RfLuc for tracking of the transplanted hMSCs via intratracheal (i.t.) administration in BLM-induced PF. (Image by SINANO) 

Contact

ZHANG Zhijun

Suzhou Institute of Nano-Tech and Nano-Bionics

E-mail:

CT/Bioluminescence Dual‐Modal Imaging Tracking of Mesenchymal Stem Cells in Pulmonary Fibrosis

Related Articles
Contact Us
  • 86-10-68597521 (day)

    86-10-68597289 (night)

  • 86-10-68511095 (day)

    86-10-68512458 (night)

  • cas_en@cas.cn

  • 52 Sanlihe Rd., Xicheng District,

    Beijing, China (100864)

Copyright © 2002 - Chinese Academy of Sciences